Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Blockmans

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Clinical Chemistry|March 7, 2009
Heterogeneous nuclear ribonucleoprotein h1, a novel nuclear autoantigenKarolien Van den Bergh, Herbert Hooijkaas, Daniel Blockmans, et al.
Acta Clinica Belgica|September 12, 2017
Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosisKarin Melsens, Els Vandecasteele, Ellen Deschepper, et al.
The New England Journal of Medicine|April 2, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell ArteritisDaniel Blockmans, Sara K Penn, Arathi R Setty, et al.
Annals of the Rheumatic Diseases|June 20, 2025
The TFIID complex is a new autoantibody target in systemic sclerosisJean-Baptiste Vulsteke, Birthe Michiels, Vanessa Smith, et al.
Journal of Autoimmunity|October 2, 2019
Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factorThibault Maillet, Tiphaine Goletto, Guillaume Beltramo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2011
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs, Matthias Briel, Thomas Daikeler, et al.
Clinical Chemistry and Laboratory Medicine|October 7, 2020
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paperXavier Bossuyt, Jan Damoiseaux, Niels Rasmussen, et al.
Annals of the Rheumatic Diseases|January 24, 2018
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceChristian Dejaco, Sofia Ramiro, Christina Duftner, et al.
NEJM Evidence|June 3, 2026
Secukinumab for Giant Cell ArteritisJohn H Stone, Nils Venhoff, Frank Buttgereit, et al.
Autoimmunity Reviews|August 7, 2017
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndromeFrançois-Xavier Danlos, Giovanni Maria Rossi, Daniel Blockmans, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Clinical Chemistry|March 7, 2009
Heterogeneous nuclear ribonucleoprotein h1, a novel nuclear autoantigenKarolien Van den Bergh, Herbert Hooijkaas, Daniel Blockmans, et al.
Acta Clinica Belgica|September 12, 2017
Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosisKarin Melsens, Els Vandecasteele, Ellen Deschepper, et al.
The New England Journal of Medicine|April 2, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell ArteritisDaniel Blockmans, Sara K Penn, Arathi R Setty, et al.
Annals of the Rheumatic Diseases|June 20, 2025
The TFIID complex is a new autoantibody target in systemic sclerosisJean-Baptiste Vulsteke, Birthe Michiels, Vanessa Smith, et al.
Journal of Autoimmunity|October 2, 2019
Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factorThibault Maillet, Tiphaine Goletto, Guillaume Beltramo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2011
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs, Matthias Briel, Thomas Daikeler, et al.
Clinical Chemistry and Laboratory Medicine|October 7, 2020
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paperXavier Bossuyt, Jan Damoiseaux, Niels Rasmussen, et al.
Annals of the Rheumatic Diseases|January 24, 2018
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceChristian Dejaco, Sofia Ramiro, Christina Duftner, et al.
NEJM Evidence|June 3, 2026
Secukinumab for Giant Cell ArteritisJohn H Stone, Nils Venhoff, Frank Buttgereit, et al.
Autoimmunity Reviews|August 7, 2017
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndromeFrançois-Xavier Danlos, Giovanni Maria Rossi, Daniel Blockmans, et al.
Pageof 15